Cargando…
Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission
The prognosis of acute promyelocytic leukemia (APL) has been improved by the combination of all-trans retinoic acid (ATRA) with chemotherapy. Nonetheless, relapse occurs in a certain proportion of patients, mostly within three to four years after treatment. We herein report a patient treated with AT...
Autores principales: | Sakurai, Masatoshi, Watanuki, Shintaro, Kato, Jun, Hashida, Risa, Yamane, Yusuke, Karigane, Daiki, Mitsuhashi, Takayuki, Murata, Mitsuru, Ueno, Hironori, Nakazato, Tomonori, Okamoto, Shinichiro, Mori, Takehiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287980/ https://www.ncbi.nlm.nih.gov/pubmed/29984744 http://dx.doi.org/10.2169/internalmedicine.0807-18 |
Ejemplares similares
-
Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI
por: Matsushita, Maiko, et al.
Publicado: (2015) -
Successful treatment of breakthrough disseminated Trichosporon asahii fungemia in a patient with acute myeloid leukemia receiving itraconazole prophylaxis
por: Karigane, Daiki, et al.
Publicado: (2017) -
Transient spontaneous remission in acute promyelocytic leukemia--two case reports.
por: Kang, H. J., et al.
Publicado: (1993) -
Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission
por: Borutinskaitė, Veronika, et al.
Publicado: (2022) -
CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients
por: Matsushita, M, et al.
Publicado: (2017)